These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 22326415)
1. Synthesis and antileukemic activity of 16E-[4-(2-carboxy)ethoxybenzylidene]-androstene amides. Bansal R; Acharya PC Steroids; 2012 Apr; 77(5):552-7. PubMed ID: 22326415 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)benzylidene]androstene derivatives as potent cytotoxic agents. Bansal R; Guleria S Steroids; 2008 Dec; 73(14):1391-9. PubMed ID: 18694772 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, evaluation and QSAR studies of 16-(4 & 3,4-substituted) benzylidene androstene derivatives as anticancer agents. Dubey S; Kaur P; Jindal DP; Satyanarayan YD; Piplani P Med Chem; 2008 May; 4(3):229-36. PubMed ID: 18473915 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro antineoplastic evaluation of certain 16-(4-substituted benzylidene) derivatives of androst-5-ene. Dubey S; Piplani P; Jindal DP Chem Biodivers; 2004 Oct; 1(10):1529-36. PubMed ID: 17191796 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives. Kassab AE; Gedawy EM Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer. Gududuru V; Hurh E; Dalton JT; Miller DD Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives. Patil V; Tilekar K; Mehendale-Munj S; Mohan R; Ramaa CS Eur J Med Chem; 2010 Oct; 45(10):4539-44. PubMed ID: 20667627 [TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2,4-dione. Romagnoli R; Baraldi PG; Salvador MK; Camacho ME; Balzarini J; Bermejo J; Estévez F Eur J Med Chem; 2013 May; 63():544-57. PubMed ID: 23537942 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth. Xu F; Jia Y; Wen Q; Wang X; Zhang L; Zhang Y; Yang K; Xu W Eur J Med Chem; 2013 Jun; 64():377-88. PubMed ID: 23644219 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines. Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505 [TBL] [Abstract][Full Text] [Related]
11. Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study. Nakhjiri M; Safavi M; Alipour E; Emami S; Atash AF; Jafari-Zavareh M; Ardestani SK; Khoshneviszadeh M; Foroumadi A; Shafiee A Eur J Med Chem; 2012 Apr; 50():113-23. PubMed ID: 22341788 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives. Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents. Gurupadaswamy HD; Girish V; Kavitha CV; Raghavan SC; Khanum SA Eur J Med Chem; 2013 May; 63():536-43. PubMed ID: 23535322 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activities of 2-amino-thiazole-5-carboxylic acid phenylamide derivatives. Liu W; Zhou J; Qi F; Bensdorf K; Li Z; Zhang H; Qian H; Huang W; Cai X; Cao P; Wellner A; Gust R Arch Pharm (Weinheim); 2011 Jul; 344(7):451-8. PubMed ID: 21598297 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of heteroaryldiamides and heteroaryldiamines as cytotoxic agents, apoptosis inducers and caspase-3 activators. Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Sanmartín C; Palop JA Arch Pharm (Weinheim); 2006 Apr; 339(4):182-92. PubMed ID: 16572481 [TBL] [Abstract][Full Text] [Related]
16. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells. Palchaudhuri R; Hergenrother PJ Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin. Antoszczak M; Maj E; Stefańska J; Wietrzyk J; Janczak J; Brzezinski B; Huczyński A Bioorg Med Chem Lett; 2014 Apr; 24(7):1724-9. PubMed ID: 24631190 [TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antitumor activity of arylsubstituted imidazolin-2-one derivatives]. Cheng YF; Hu YZ; He QJ Yao Xue Xue Bao; 2005 Aug; 40(8):711-6. PubMed ID: 16268505 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives. Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic studies of hydroximino derivatives of some 16E-arylidenosteroids. Chattopadhaya R; Jindal DP; Minu M; Gupta R Arzneimittelforschung; 2004; 54(9):551-6. PubMed ID: 15500202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]